Abattis Bioceuticals Corp.
ATTBF · OTC
9/30/2019 | 9/30/2018 | 9/30/2017 | 9/30/2016 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $2,019 | $4,064 | $526 | $38 |
| Short-Term Investments | $383 | $5,032 | $0 | $0 |
| Receivables | $155 | $0 | $128 | $1 |
| Inventory | $268 | $30 | $0 | $0 |
| Other Curr. Assets | $777 | $767 | $25 | $13 |
| Total Curr. Assets | $3,602 | $10,462 | $679 | $91 |
| Property Plant & Equip (Net) | $757 | $725 | $530 | $149 |
| Goodwill | $3,161 | $0 | $0 | $0 |
| Intangibles | $11,690 | $0 | $0 | $1,026 |
| Long-Term Investments | $51 | $213 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $2 | $2 |
| Total NC Assets | $15,659 | $938 | $532 | $1,177 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $19,261 | $11,399 | $1,211 | $1,268 |
| Liabilities | – | – | – | – |
| Payables | $220 | $224 | $231 | $608 |
| Short-Term Debt | $1,446 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $3,247 | $80 | $209 | $419 |
| Total Curr. Liab. | $4,913 | $303 | $439 | $1,027 |
| LT Debt | $124 | $0 | $0 | $31 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $3,558 | $0 | $0 | $0 |
| Total NC Liab. | $3,682 | $0 | $0 | $31 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $151 | $0 | $0 | $0 |
| Total Liabilities | $8,594 | $303 | $439 | $1,058 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $114,451 | $108,842 | $22,104 | $14,714 |
| Retained Earnings | -$101,707 | -$99,798 | -$22,744 | -$15,154 |
| AOCI | -$186 | $2,000 | -$178 | $1,000 |
| Other Equity | -$1,481 | $0 | $2,343 | $111 |
| Total Equity | $11,077 | $11,487 | $1,525 | $671 |
| Supplemental Information | – | – | – | – |
| Minority Interest | -$410 | -$391 | -$753 | -$461 |
| Total Liab. & Tot. Equity | $19,261 | $11,399 | $1,211 | $1,268 |
| Net Debt | -$450 | -$4,064 | -$526 | -$8 |